X
Cookies help us improve your website experience.
By using our website, you agree to our use of cookies.


Latest Post

September 02, 2020

SARS-CoV-2 Vaccines – Alternative Vial Components

The need to provide vaccines for the SARS-CoV-2 pandemic has presented the pharmaceutical industry with unprecedented challenges. Among them are accelerated timelines for development/approval and unanticipated volumes for manufacture/delivery. Ordinarily for a new drug product, there is ample time for selecting the primary package system and establishing component availability.
Whitney Winters

Whitney Winters

Sr. Director, Strategic Marketing, Containment Systems

Previous Posts
Load more